Inhibition of angiogenesis and invasion in malignant gliomas-Reference-Cited by-同舟云学术

Inhibition of angiogenesis and invasion in malignant gliomas

Published:2007-11 Issue:11 Volume:7 Page:1537-1560
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Chi Andrew,Norden Andrew D,Wen Patrick Y

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1586/14737140.7.11.1537

Reference288 articles.

1. World Health Organization Classification of Tumours. Pathology and Genetics: Tumours of the Nervous System. Kleihues P, Cavenee W (Eds). IARC Press, Lyon, France (2000).

2. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

3. Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials

4. Angiogenesis as a therapeutic target

5. Angiogenic inhibitors: a new therapeutic strategy in oncology

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma;Frontiers in Oncology;2021-03-30

2. Spectroscopic Investigations and DFT Studies of Synthesized 4- Acetamidophenyl 3,4,5-Trimethoxybenzoate and 4-acetyl phenyl 3,4,5- trimethoxybenzoate a Novel Conjugate of Gallic Acid;Letters in Organic Chemistry;2021-02

3. Gallic Acid as a Putative Antioxidant in Usage Against Liver Disease;The Liver;2018

4. Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4;Oncotarget;2017-03-10

5. Molecularly targeted therapies for recurrent glioblastoma: current and future targets;Neurosurgical Focus;2014-12